Price target
12.640.000.00%
The 11 analysts offering 1 year price forecasts for PRME have a max estimate of — and a min estimate of —.
Analyst rating
Based on 12 analysts giving stock ratings to PRME in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PRME EPS for the last quarter is −0.44 USD despite the estimation of −0.39 USD. In the next quarter EPS is expected to reach −0.36 USD. Track more of Prime Medicine, Inc. financials and stay on top of what is up with the company.
In the next quarter Prime Medicine, Inc. revenue is expected to reach 9.75 M USD. Check out Prime Medicine, Inc. revenue and earnings and make informed decisions.
According to analysts, PRME price target is 12.64 USD with a max estimate of 19.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch Prime Medicine, Inc. stock price chart and keep track of the current situation with PRME news and stock market news.
We've gathered opinions of 12 analysts rating PRME stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.